Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,876.21
    +203.55 (+0.40%)
     
  • CMC Crypto 200

    1,327.48
    +50.50 (+3.96%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

June Best Growth Stocks

Looking to add potential meaningful upside to your portfolio, but unsure where to start? Stocks such as Globant and Cytokinetics are considered to be high growth in terms of how much they’re expected to earn and return to shareholders, according to the market. If a buoyant growth prospect is what you’re after in your next investment, I’ve put together a list of high-growth stocks you may be interested in, based on the latest financial data from each company.

Globant S.A. (NYSE:GLOB)

Globant S.A., a technology services company, provides services related to application development, testing, infrastructure management, and application maintenance worldwide. Formed in 2003, and currently lead by Martín Migoya, the company employs 6,940 people and with the market cap of USD $1.90B, it falls under the small-cap category.

ADVERTISEMENT

Driven by the positive double-digit sales growth of 43.68% over the next few years, GLOB is expected to deliver an excellent earnings growth of 26.92%. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 20.81%. GLOB’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Thinking of investing in GLOB? I recommend researching its fundamentals here.

NYSE:GLOB Future Profit Jun 5th 18
NYSE:GLOB Future Profit Jun 5th 18

Cytokinetics, Incorporated (NASDAQ:CYTK)

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. Established in 1997, and currently lead by Robert Blum, the company employs 137 people and with the company’s market cap sitting at USD $444.42M, it falls under the small-cap stocks category.

CYTK’s projected future profit growth is a robust 43.98%, with an underlying triple-digit growth from its revenues expected over the upcoming years. An affirming signal is when net income increase is supported by top-line growth. Since net income isn’t artificially inflated by one-off initiatives such as cost-cutting, we know this profit growth is more likely to be sustainable. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 97.64%. CYTK’s bullish prospects on both the top and bottom lines make it an interesting stock to invest more time to understand how it can add value to your portfolio. Should you add CYTK to your portfolio? Have a browse through its key fundamentals here.

NasdaqGS:CYTK Future Profit Jun 5th 18
NasdaqGS:CYTK Future Profit Jun 5th 18

Noah Holdings Limited (NYSE:NOAH)

Noah Holdings Limited, through its subsidiaries, operates as a wealth and asset management service provider with focus on wealth investment and asset allocation services for high net worth individuals and enterprises in the People’s Republic of China. Started in 2005, and currently lead by Jingbo Wang, the company currently employs 2,969 people and with the company’s market capitalisation at USD $3.69B, we can put it in the mid-cap category.

NOAH is expected to deliver a buoyant earnings growth over the next couple of years of 23.09%, bolstered by an equally impressive revenue growth of 66.12%. Profit growth, coupled with top-line expansion, is a positive indication. This is because net income isn’t artificially inflated by unsustainable activities such as one-off cost-reductions expected in the future. We see this bottom-line expansion directly benefiting shareholders, with expected return on equity coming in at a notable 21.29%. NOAH ticks the boxes for high-growth generation on all levels of line items, which makes it an appealing stock to dig into deeper. Thinking of investing in NOAH? Take a look at its other fundamentals here.

NYSE:NOAH Future Profit Jun 5th 18
NYSE:NOAH Future Profit Jun 5th 18

For more financially robust companies with high growth potential to enhance your portfolio, explore this interactive list of fast growing companies.


To help readers see pass the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned.